Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Gian Domenico Sebastiani, Enrique de Ramón Garrido, Maria Giovanna Danieli, Daniel Abramovicz, Daniël Blockmans, Alessandro Mathieu, Haner Di̇reskeneli̇, Mauro Galeazzi, Ahmet Gül, Yair Levy, P Petera, Rajko Popović, Radmila Petrović, Renato Alberto Sinico, Roberto Cattaneo, Josep Font, Geneviève Depresseux, Jean‐Pierre Cosyns, Ricard Cervera

Arthritis & Rheumatism, 2002

UCLouvain, Cliniques Universitaires Saint-Luc, Hospital de Santo António, Royal London Hospital, Ospedale generale di zona San Camillo Treviso, Hospital Regional Universitario de Málaga, Ospedali Riuniti di Ancona, Université Libre de Bruxelles, KU Leuven, University of Cagliari, Marmara University, University of Siena, Istanbul University, Tel Aviv University, Sheba Medical Center, Klinik Hietzing, Military Medical Academy, University of Belgrade, Ospedale San Carlo, University of Brescia, Universitat de Barcelona

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with Arthritis & Rheumatism. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

1060

Citations

View on Google Scholar

Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

Abstract

Journal Details

Join JournalsHub

Welcome Back